|
AERs in Aphasia: Severity and Improvement Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for qualified medical advice, visits or professional assistance by using a real mD. We are not docs. Always confer with your physician about AERs in Aphasia: Severity and Improvement conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. AERs in Aphasia: Severity and Improvement Clinical research trials and AERs in Aphasia: Severity and Improvement health trials occur in many of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectivity of new does drugs. The intent of the studies / undertakings is to resolve particular human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to detect remedies for all sorts of conditions, including AERs in Aphasia: Severity and Improvement. AERs in Aphasia: Severity and Improvement Clinical Trials and other clinical trials permit volunteers to obtain healthcare treatment alternatives before they are available to the masses. Most times the participants undergo professional assistance for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a AERs in Aphasia: Severity and Improvement clinical trial. Test subjects typically receive the most expert healthcare available for their AERs in Aphasia: Severity and Improvement condition. Dangers are a reality, however, and may include more or frequent mD visits, healthcare dangers (perhaps life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > AERs in Aphasia: Severity and Improvement  AERs in Aphasia: Severity and Improvement
AERs in Aphasia: Severity and Improvement
For Condition: Stroke
Status: No longer recruiting
Sponsor(s): Department of Veterans Affairs ,
Synopsis: Over one million persons in the United States are aphasic subsequent to a stroke. Most of the individuals improve through spontaneous recovery and treatment. However, there are no precise methods for predicting which patients will improve and, for those who do, how much improvement will occur. There is a need to improve prognostic precision in aphasia. The purpose of this investigation is to test the precision of auditory evoked responses (AERs) to provide a prognosis for improvement in aphasia subsequent to a left hemisphere thromboembolic infarct. We hypothesize that the presence, absence, and pattern of the AER responses will predict severity of aphasia and prognosis for improvement. Phonemic, phonologic, semantic, and syntactic language tasks will be used to elicit AERs, including the auditory late response, the mismatch negativity response (MMN), the N400, and the P600.
Details: Over one million persons in the United States are aphasic subsequent to a stroke. Most of the individuals improve through spontaneous recovery and treatment. However, there are no precise methods for predicting which patients will improve and, for those who do, how much improvement will occur. There is a need to improve prognostic precision in aphasia. Currently employed prognostic methods miss improvement levels by substantial margins. Prognostic information could have a great economic and social impact on patients, their families, and their treatment. The purpose of this investigation is to test the precision of auditory evoked responses (AERs) to provide a prognosis for improvement in aphasia subsequent to a left hemisphere thromboembolic infarct. We hypothesize that the presence, absence, and pattern of the AER responses will predict severity of aphasia and prognosis for improvement. Phonemic, phonologic, semantic, and syntactic language tasks will be used to elicit AERs, including the auditory late response, the mismatch negativity response (MMN), the N400, and the P600. Twenty moderately aphasic subjects, 20 severely aphasic subjects, and 20 age-matched, normal subjects will be tested. All aphasic subjects will be evaluated with the AER test battery and a language test battery: Western Aphasia Battery (WAB), Porch Index of Communicative Ability (PICA), the Token Test (TT), the Auditory Comprehension Test for Sentences (ACTS), and the ASHA Functional Assessment of Communication Skills for Adults (ASHA FACS). All tests will be repeated in 6 and 12 weeks, during which the aphasic subjects will receive treatment. Aphasic subjects will receive follow-up testing 3 and 6 months after the treatment phase is completed. The patterns of the AERs will be examined. Correlations and analyses of variance (ANOVAs) will be used to assess the relationships between AER measures and improvement in aphasia quantified by behavioral measures. A multiple regression technique will be used to determine the best predictor(s) of improvement in aphasia. Correlations and analyses of variance (ANOVAs) will be used to assess the relationship between AER measures and severity of aphasia. Correlations and assessment of composite CT/MRI reconstructions for subject groups will be used to determine the relationship between size (correlations) and site of lesion, AERs, and severity and improvement in aphasia.
Eligibility:
Study Type: Observational, Screening, Longitudinal, Defined Population, Prospective Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Stroke patients
Total Enrollment: 20
Location and Contact Information:
Overall Study Official:
JohnFryer, , Department of Veterans Affairs, Program Analysis and Review Section (PARS), Rehabilitation Research & Development Service
VAMC, Nashville
Nashville, Tennessee,
United States
Additional Information:
Study ID Numbers: C2133;
Study Start Date: January 2000
Record last reviewed: January 2001
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00013442
Other Stroke Studies:
1. A Phase II Pilot Study of the Safety, Tolerability and Pharmacokinetics of Cerebrilâ„¢ in Patients with Lobar Hemorrhage Related to Cerebral Amyloid Angiopathy
2. Women's Estrogen for Stroke Trial (WEST)
3. Motor Learning in Stroke Patients and Healthy Volunteers
4. Treatment for Post-Stroke Depression
5. Silent Cerebral Infarct Multi-Center Clinical Trial
Related Studies:
Other Stroke Clinical Trials
Other Tennessee Clinical Trials
Other Nashville Clinical Trials
AERs in Aphasia: Severity and Improvement
|
|
|
|
|
|
|
|
